Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Vet
Pets & Animals/Pet Medications

Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy: Cyclosporine 2% Ophthalmic Solution Recalled for Lack of Sterility

Agency Publication Date: April 16, 2019
Share:
Sign in to monitor this recall

Summary

Anderson Compounding Pharmacy has voluntarily recalled 4 containers of its Cyclosporine 2% Ophthalmic Solution (10 mL) intended for veterinary use. The recall was initiated because the product lacks sterility assurance, meaning the solution might be contaminated with microorganisms that could cause infection. This medication was distributed to customers in Tennessee and Virginia and is identified by the NDC number 99999-0007-76.

Risk

A lack of sterility in an ophthalmic (eye) solution poses a significant risk of infection to the animal's eyes, which could lead to inflammation, irritation, or more serious vision complications if a pathogen is introduced during treatment.

What You Should Do

  1. Check your veterinary medication for 'Anderson Compounding Pharmacy Cyclosporine 2% Ophthalmic Solution 10 MLS' with NDC 99999-0007-76 in a 10 mL drop container.
  2. Verify the specific batch information on the label: Look for Lot number 10242018@15 and a Beyond Use Date (BUD) of 4/22/2019.
  3. Stop using the medication immediately if it matches the recalled lot number.
  4. Contact your veterinarian or pharmacist to discuss alternative treatments and to report any adverse effects your pet may have experienced.
  5. Return any unused portion of the product to Anderson Compounding Pharmacy at 310 Bluff City Hwy, Bristol, TN 37620 for a refund.
  6. Contact Anderson Compounding Pharmacy at 1-800-263-8890 for further instructions regarding the return process.
  7. For additional questions or to report safety concerns, contact the FDA Center for Veterinary Medicine at 1-240-402-7002.

Your Remedy Options

๐Ÿ’ฐFull Refund

Pharmacy-led drug recall remedy

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund and contact the manufacturer for further instructions.

Affected Products

Product: Anderson Compounding Pharmacy Cyclosporine 2% Ophthalmic Solution (10 mL)
Model:
NDC 99999-0007-76
Recall #: V-0125-2019
Lot Numbers:
10242018@15 (BUD: 4/22/2019)
Date Ranges: BUD: 4/22/2019

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 82555
Status: Resolved
Manufacturer: Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy
Sold By: Anderson Compounding Pharmacy
Manufactured In: United States
Units Affected: 4 drop containers
Distributed To: Tennessee, Virginia
Agency Last Updated: April 23, 2019

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response